The global Diabetic Retinopathy market is undergoing a period of significant expansion, primarily driven by the escalating global prevalence of diabetes. Diabetic retinopathy (DR), a microvascular complication of diabetes mellitus, remains the leading cause of preventable blindness in the working-age population worldwide. As of 2024, the market was valued at USD 8.43...